Authors: Lightner AL, Vogel JD, Carmichael JC, et al.
Description: Updated guideline by the American Society of Colon and Rectal Surgeons Clinical Practice Guidelines Committee.
Diseases of the Colon & Rectum: August 2020 – Volume 63 – Issue 8 – p 1028-1052
doi: 10.1097/DCR.0000000000001716
Authors: Gernandez LM, Figueiredo NL, Habr-Gama A, et al.
Description: Although patients with baseline cT2 rectal cancer had similar pathologic stage at the time of recurrence, these patients were more likely to continue an organ preservation pathway after local regrowth through transanal local excision when compared with cT3 to cT4. Despite differences in the use of radical salvage resection, there were no differences in oncologic outcomes.
Link to publication: https://journals.
Diseases of the Colon & Rectum: August 2020 – Volume 63 – Issue 8 – p 1053-1062
doi: 10.1097/DCR.0000000000001707
Authors:: Sho S, Yothers G, Colangelo LH, et al.
Description: Wide variations in the quality of pathology reporting are observed for rectal cancer The National Accreditation Program for Rectal Cancer mandates that programs meet strict quality standards for surgical pathology reporting. Further improvement is needed in this key aspect of oncology care for patients with rectal cancer.
Diseases of the Colon & Rectum: August 2020 – Volume 63 – Issue 8 – p 1063-1070
doi: 10.1097/DCR.0000000000001578
Authors: O’Brien SJ, Chen RC, Stephen VT, et al.
Description: Preoperative opioid prescription was a significant risk factor for adverse outcomes in patients with Crohn’s disease undergoing elective ileocolic resection.
Diseases of the Colon & Rectum: August 2020 – Volume 63 – Issue 8 – p 1090-1101
doi: 10.1097/DCR.0000000000001571
Title: Opioid prescriptions after hemorrhoidectomy
Authors: Lu PW, Fields AC, Andriotti T, et al.
Description: There is wide variability in the length of prescription opioid use after hemorrhoidectomy. Approximately one third of patients require a second prescription in the immediate postoperative period. The optimal duration appears to be between a 5- and 10-day supply. Clinicians may be able to more efficiently discharge patients with adequate analgesia while minimizing the potential for excess supply.
Diseases of the Colon & Rectum: August 2020 – Volume 63 – Issue 8 – p 1118-1126
doi: 10.1097/DCR.0000000000001570
Title: The artificial bowel sphincter in the treatment of fecal incontinence, long-term complications
Authors: van der Wilt AA, Breukink SO, sturkenboom R, et al.
Description: Patients with severe end-stage fecal incontinence can benefit from artificial bowel sphincter, but this requires a large number of reoperations, and at least 20% of patients will eventually have a colostomy. Therefore, careful patient selection and the involvement of patients in decision making regarding the potential benefits and limitations of this technique are paramount.
Diseases of the Colon & Rectum: August 2020 – Volume 63 – Issue 8 – p 1134-1141
doi: 10.1097/DCR.0000000000001683
Original post https://alertarticles.info